Printer Friendly

Bioactivity of alkamides isolated from Echinacea purpurea (L.) Moench.

Summary

Alkamides from the roots of Echinacea purpurea (L.) Moench were examined for anti-inflammatory activity in an in vitro model system. Cyclooxygenase-I (COX-I) and cyclooxygenase-II (COX-II) inhibitory activities were assessed at pH 7 for alkamides isolated from E. purpurea roots to compare inhibitory activities between the two cyclooxygenase isozymes. At 100 [micro]g/ml, several E. purpurea alkamides inhibited COX-I and COX-II enzymes in the range of 36-60% and 15-46%, respectively, as compared to controls. Mosquitocidal activity was assessed at 100 and 10 [micro]g/ml, with 100% mortality against Aedes aegyptii L. larvae noted for several E. purpurea alkamides at 100 [micro]g/ml.

Key words: Echinacea purpurea, alkamides, cyclooxygenase, enzyme, Aedes aegyptii, mosquitocidal

* Introduction

Echinacea purpurea is one of three Echinacea species used widely for phytoceutical purposes. Initially used by North American Indians to treat various infections, the use of Echinacea spread to Europe where Echinacea-based products have flourished in the natural product supplement market (Bauer and Wagner, 1991). Following the establishment of Echinacea products in the European market, interest in Echinacea spp. has increased in the North American nutraceutical market, where the popularity of Echinacea products has grown as a complement to modern medicine (Borchers et al., 2000). Proof of safety and efficacy of herbal supplements would aid in consumer confidence.

Many adverse side-effects, including upper gastrointestinal irritation and ulceration, have been reported after long-term use of COX-I inhibitors such as aspirin (Loll, 1996). COX-I is the constitutive form of the enzyme responsible for basic regulatory functions in cells and is involved in the production of prostaglandins (Cryer and Dubois, 1998). Because prostaglandins are responsible for such physiological process as control of gastric secretions and maintenance of mucosal integrity (Ford-Hutchinson, 1996), inhibition of COX-I may lead to the adverse side-effects noted for long-term non-steroidal anti-inflammatory drug (NSAID) use. COX-II, the cyclooxygenase isozyme inducible in response to inflammation (Lipisky, 1999), is believed to possibly inhibit inflammation without the adverse side-effects noted for COX-I inhibitors (Pairet et al., 1996; Vane and Botting, 1996). Compounds with relatively greater COX-Il inhibition, as compared to COX-I, have demonstrated anti-inflammatory activity with a reduction of adverse side-effects in preclinical trials (Ford-Hutchinson, 1996). Specific of greater inhibition of COX-II as opposed to COX-I is a desirable target in developing pharmaceutical and phytoceutical products, due to the potential reduction in adverse side-effects.

Numerous bioactive compounds have been isolated from Echinacea spp. Extracts and compounds from various parts of Echinacea spp. plants have demonstrated anti-viral, antioxidant, and anti-inflammatory activites (Facino et al., 1995; Bauer and Wagner, 1991; Wagner et al., 1998; Luettig et al., 1989). Of particular interest are the alkamides isolated from E. purpurea and E. angustifolia, some of which have been examined for in vitro anti-inflammatory activity. Inhibition of 5-lipoxygenase and cyclooxygenase enzymes isolated from ram seminal vesicles by alkamides present in E. angustifolia and F. purpurea has been reported previously (Muller-Jakic et al., 1994). Two cyclooxygenase isoforms have been identified, COX-I and COXII; however, a comparative assessment of the COX-Iversus the COX-II-inhibitory properties of the alkamides has not been completed. In this paper we report the comparative COX-I- and COX-II-inhibition exhibited by E. purpurea alkamides.

In addition to anti-inflammatory properties, alkamides from a variety of plants have been reported to possess significant mosquitocidal activity. The mosquitocidal activity of dodeca-2E,4E,8E, 1OZ-tetraenoic acid isobutylamide, an alkamide isolated from Spilanthes mauritiana (Jondiko, 1986), is of interest due to its close structural similarity to an alkamide identified from E. purpurea. The mosquitocidal activites of the majority of alkamides from F. purpurea have not been determined. Therefore, the mosquitocidal properties of alkamides from E. purpurea were also evaluated.

Materials and Methods

General Experimental

Preparative HPLS was performed using a Model LC-20 Preparative Recycling Liquid Chromatograph (Japan Analytical Instrument Co., Ltd., Tokyo, Japan) with UV detection at 260 nm. A gradient of methanol:water (50-80% methanol over 2 h) was used to separate the alkamides into crude fractions. Final purification was achieved using a gradient of acetonitrile: water (40-60% acetonitrile over 2 h). [HNMR.sup.1] NMR spectra were recorded in [CDC1.sub.3] on a Varian Inova 300 MHz spectrometer. Mass spectra were recorded using a Waters Alliance HT LC/MS system (Milford, Massachusetts) with a 2690 Separations Module and Micromass detector (ionization mode AP+ and cone voltage 40, mobile phase 40-80% acetonitrile over 30 mm). Identification of E. purpurea alkamides was made using H-[NMR.sup.1] experiments and comparison with literature (Bauer et al., 1988) and LC7MS values.

Plant Material

E. purpurea roots were obtained from Trout Lake Farm (Trout Lake, Washington). Dried, milled E. purpurea roots (989.9 g) were extracted exhaustively using dichloromethane (4 1 x 3 days) and concentrated in vacuo. Following concentration, the dichloromethane extract (10.1 g) was separated into methanol-soluble (7.1 g) and insoluble (3.0 g) fractions, with the addition of methanol (750 ml x 3). The methanol-soluble portion was concentrated in vacuo, dissolved in chloroform (250 ml), and hexane was added. The supernatant, containing the crude alkamides, was concentrated (4.2 g) and subjected to separation through preparative high-performance liquid chromatography (HPLC).

Cyclooxygenase Inhibitory Assay

An in vitro COX-inhibition model system was used to assess the anti-inflammatory activity of alkamides isolated from E. purpurea. The COX-I used in the assay was prepared from ram seminal vesicles (Oxford Biomedical Research Inc., Oxford, MI). COX-I was obtained from microsomal preparations of ram seminal vesicles according to methods reported previously (Laneuville et al., 1994; Meade et al., 1993). A microsomal preparation of recombinant human COX-II, obtained from an insect cell lysate, was used as the source of COX-II enzyme for the assay. The assay was conducted in a 600-[micro]l Instech chamber (Instech Laboratory, Plymouth Meeting, PA) maintalned at 37 [degrees]C, containing a reaction buffer of 0.1 m Tris, 1 mM phenol, 100 [micro]M arachidonic acid, and 17 [micro]g hemoglobin. Alkamides were dissolved in DMSO such that a 10-[micro]l aliquot would yield a final assay concentration of 100 [micro]g/ml. The reaction was initiated using either a 10[micro]l aliquot of COX-I or a 20-[micro]1 aliquot of COX-I I. Oxygen uptake was monitored using a YSI model 5300 biological oxygen monitor (Yellow Springs Instruments, Inc., Yellow Springs, OH) and recorded using Quicklog for Windows, version 1.0 (Strawberry Tree, Inc., Sunnyvale, CA).

Aspirin, ibuprof en, naproxen, celecoxib (Celebrex [TM]), and rofecoxib (Vioxx [TM]) were dissolved in DMSO and used as controls for both the COX-I and COX-II inhibitory assays. Aspirin was tested at 1000 [micro]M (180 [micro]g/ml), ibuprofen at 10 [micro]M (2.06 [micro]g/ml), and naproxen at 10 [micro]M (2.52 [micro]g/ml) for both COX-I and COX-II. Celecoxib (Celebrex [TM]) and rofecoxib (Vioxx [TM]) were obtained as physican's professional samples (Dr. Subash Gupta, Sparrow Pain Center, Sparrow Hospitals, Michigan), ground to fine powder, dissolved in DMSO, and tested at 1.6 [micro]g/ml for both COX-I and COX-II.

Mosquitocidal Assay

The mosquitocidal assay was performed according to methods published previously (Kelm et al., 1998; Nair et al., 1989). Aedes aegyptii L., provided by Dr. Alan Hayes (Department of Entomology, Michigan State University) were hatched and raised in 500 ml of degassed distilled water, with approximately 5 mg of bovine liver powder added for nourishment. After the mosquito larvae had reached the fourth-instar (four days), the larvae were prepared for the bioassay. Ten to fifteen larvae in 980 [micro]l of degassed, distilled water were placed in 4-mi culture tubes. Stock solutions of the alkamides in DM80 were prepared such that a 20-[micro]l aliquot added to the mosquito larvae in the bioassay culture tubes yielded a final assay concentration of 100 [micro]g/ml or 10 [micro]g/ml. A 20-[micro]l aliquot of DM80 was used as the control. The alkamides were tested at 100 [micro]g/ml and 10 [micro]g/m1 in triplicate with the control set. Dead larvae were recorded at time zero, 1, 2, 4, 9, and 24 h, and reported in term s of percent mortality.

Results

The bioactive alkamides isolated from dried E. purpurea roots (Figure 1) were identified as undeca-2E-4Zdien-8, 10-diynoic acid isobutylamide (1), undeca2Z,4E-dien-8, 10-diynoic acid isobutylamide (2), dodeca-2E,4Z-dien-8, 10-diynoic acid isobutylamide (3), undeca-2E,4Z-dien-8, 10-diynoic acid 2-methylbutylamide (4), dodeca-2E,4Z-dien-8, 10-diynoic acid 2-methylbutylamide (5), and a mixture of dodeca-2E,4E,8Z,1OEtetraenoic acid isobutylamide and dodeca2E,4Z,8Z, 10Z-tetraenoic acid isobutylamide (6/7). Compounds 6 and 7 were inseparable under varioius HPLC conditions. Yields obtained were 8 mg (1), 14 mg (2), 21 mg (3), 12 mg (4), 15 mg (5), and 40 mg (6/7).

The results of the mosquitocidal assay are summarized in Figure 2. The mixture of alkamides 6/7 proved to be the most effective in the mosquitocidal assay, with 87.5% mortality of mosquito larvae within 15 min when assayed at a concentration of 100 [micro]g/ml. Lowering the concentration to 10 [micro]g/ml still yielded significant mosquitocidal activity, with 63% mortality in one hour (Figure 2). Mosquito larvae that were still regarded as alive showed significant impairment at 1 h and beyond for alkamides 6/7. Compound 1 demonstrated slightly less activity with 71 and 100% mortality by 2 and 9 h, respectively. Compounds 2 and 3 showed mosquitocidal activity at the end of 9 h, with 78 and 50% mortality, respectively. Alkamides 4 and 5 proved to be the least active, with only 25 and 10% mortality at the end of 24 h.

COX-I and COX-II inhibitory activities of the alkamides are summarized in Figure 3 COX-I inhibitory activity was highest for alkamides 2, 4, and 5, with inhibitions of 60, 55, and 48%, respectively. Alkamides 1 and 3 both exhibited COX-I inhibition of 36% as compared to DMSO. The mixture of alkamides 6/7 did not, however, demonstrate inhibition of the COX-I enzyme (Figure 3).

The alkamides showed lower COX-II inhibitory activity as compared to COX-I. Compound 2 possessed the strongest COX-II inhibitory activity at 46%. Compounds 4 and 5 showed 39 and 31% inhibition of the COX-II enzyme, respectively. Compounds 1 and 3 had the lowest activities of the alkamides, with each exhibiting 15% inhibition. As with COX-I, the mixture of alkamides 6/7 did not demonstrate activity against COX-II.

Discussion

Numerous plant species of the Asteraceae contain insecticidal alkamides (Greger, 1984), and the mosquitocidal properties of E. angustifolia have been reported previously (Hartzell, 1947; Greger, 1984). Dodeca-2E,4E,8Z, 10E-tetraenoic acid isobutylamide, an alkamide isolated from S. mauritiana (Jondiko, 1986) similar in structure to 6/7 identified from E. purpurea (Bauer et al., 1988) and E. angustifolia (Bauer and Wagner, 1991), showed 100% mortality at 24 h against A. aegyptii at [10.sup.-5] mg/ml (Jondiko, 1986). In our study, the high activity noted for alkamides 6 and 7 from E. purpurea supports the mosquitocidal activity indicated from E. angustifolia.

Interestingly, both 2-methylbutylamides, 4 and 5, demonstrated the lowest mosquitocidal activity in the assay as compared to the isobutylamides tested. The presence of an E/Z configuration of the double bonds is regarded as important for conveying the highest degree of insecticidal, and thus biological, activity (Greger, 1984). From the results of the mosquitocidal assay, it appears that the 2-methyl versus an isobutyl functionality may also play a role in the effectiveness of alkamides as mosquitocidal compounds.

Previously, eight alkamides from E. angustifolia D.C. and ten alkamides from various Achillea species were examined for cyclooxygenase and 5-lipoxygenase activities (Muller-Jackic et al., 1994). A mixture of 6/7, isolated from E. angustifolia roots, demonstrated 54% inhibition of COX from microsomal sheep seminal vesicle preparations at a concentration of 50 [micro]/ml. The mixture of 6/7 isolated from E. purpurea roots in our study did not show activity at 100 [micro]g/ml for either COX-I or COX-II. Alkamides 1-5 from E. purpurea roots have not been examined for cyclooxygenase inhibitory activity; however, undeca-2E,4E-diene-8, 10-diynoic acid isobutylamide, isolated from Achillea millefolium L., was shown to inhibit COX-I enzyme at 40% (Muller-Jakic et al., 1994), while compounds 1 and 2 exhibited 36 and 60% COX-I enzyme inhibition, respectively.

Compound 2 exhibited the highest inhibition against both COX-I and COX-II enzymes. The 2-methylbutylamides, compounds 4 and 5, demonstrated higher COX-I and COX-II inhibitory activity when compared to the majority of the isobutylamides tested, with the exception of compounds 2. Compounds 1 and 3, differing in one methyl group, demonstrated equal inhibitory activities for both COX-I and COX-II enzymes, indicating that the inhibition of COX-I and COX-II enzymes is unaffected by the addition of a single methyl group.

The E. purpurea alkamides examined in this study did not show selective inhibition of COX-II enzyme. Additional work in identifying the structure activity relationships of E. purpurea alkamides and alkamides of similar structure differing in E/Z configurations would aid in determining the potency of these alkamides for specific phytoceutical applications.

[FIGURE 2 OMITTED]

[FIGURE 3 OMITTED]

Acknowledgements

The authors would like to thank Dr. Steve Missler for performing the LC/MS analysis and Dr. Subash Gupta of the Sparrow Pain Center (Lansing, Michigan) for providing the celecoxib (Celebrex[TM]) and rofecoxib (Vioxx[TM]) physician's professional samples.

References

Bauer, R., Reminger, P., Wagner, H.: Alkamides from the roots of Echinacea purpurea. Phytochemistry 27(7): 2339-2342, 1988.

Bauer, R., Wagner, H.: Echinacea species as potential immunostimulatory drugs. In: Economic and Medicinal Plant Research. Eds.: H. Wagner, N. R. Farnsworth, Academic Press, London, pp. 253-321, 1991.

Borchers, A. T., Keen, C. L., Stern, J. S., Gershwin, M. E.: Inflammation and Native American medicine: the role of botanicals. Am. J. Clin. Nutr. 72: 339-347, 2000.

Cryer, B., Dubois, A.: The advent of highly selective inhibitors of cyclooxygenase -- a review. Prostaglandins and other lipid mediators 56: 341-361, 1998.

Facino, R. M., Carini, M., Aldini, G., Saibene, L., Pietta, P., Mauri, P.: Echinacoside and caffeoly conjugates protect collagen from free radical-induced degradation: A potential use of Echinacea extracts in the prevention of skin photodamage. Planta Med. 61: 510-514, 1995.

Ford-Hutchinson, A. W.: New highly selective cyclooxygenase-2 inhibitors. In: New targets of inflammation: Inhibitors of COX-2 or adhesion molecules. Eds.: N. Bazan, J. Botting, J. Vane, Kluwer Academic, Dordrecht, pp. 55-62, 1996.

Greger, H.: Alkamides: Structural relationship, distribution and biological activity. Planta Med. 50(5): 366-375, 1984.

Hartzell, A.: Plant products for insecticidal properties and summary of results to date. Contribs. Boyce Thompson Inst. 15: 21-34, 1947.

Jondiko, I. J. O.: A mosquito larvicide in Spilanthes mauritiana. Phytochemistry 25: 2289-2290, 1986.

Kelm, M. A., Nair, M.G.: Mosquitocidal compounds and a triglyceride, 1,3-dilinoleneoyl-2-palmitin, from Ocimum sanctum. J. Ag. Food Chem. 46: 3092-3094, 1998.

Laneuville, O., Breuer, D. K., DeWitt, D. L., Hla, T., Funk, C. D., Smith, W. L.: Differential inhibition of human prostaglandin endoperoxidase H synthases-l and -2 by nonsteroidal anti-inflammatory drugs. J. Pharmacol. Exp. Ther. 271: 927-934, 1994.

Lipisky, P. E.: The clinical potential of cyclooxygenase-2-specific inhibitors. Am. J. of Med. 106 (SB): 51S-57S, 1999.

Loll, P. J.: Structure of prostaglandin H2 synthase-1 (COX-1) and its NSAID binding sites. In: New targets of inflammation: Inhibitors of COX-2 or adhesion molecules. Eds.: N. Bazan, J. Botting, J. Vane, Kluwer Academic, Dordrecht, pp. 13-21, 1996.

Luettig, B., Steinmuller, C., Gifford, G. E., Wagner, H., Lohmann-Matthes, M.-L.: Macrophage activation by the polysaccharide arabinogalactan isolated from plant cell cultures of Echinacea purpurea. J. Nat. Cancer Inst. 81: 669-675, 1989.

Meade, E. A., Smith, W. L., DeWitt, D. L.: Differential inhibition of prostaglandin endoperoxide synthase (cyclooxygenase) isozymes by aspirin and other non-steroidal anti-inflammatory drugs. J. Biol. Chem. 268: 6610-6614, 1993.

Muller-Jakic, B., Breu, W., Probstle, A., Redl, K., Greger, H., Bauer, R.: In vitro inhibition of cyclooxygenase and 5-lipoxygenase by alkamides from Echinacea and Achillea species. Planta Med. 60: 37-40, 1994.

Nair, M. G., Putnam, A. R., Mishra, S. K., Mulks, M. H., Taft, W. H., Keller, B. E., Miller, J. R., Zhu, P.-P. Meinhart, D., Lynn, D. G.: Faeriefungin: A new broad-spectrum antibiotic from Streptomyces griseus Var. Autotrophicus. J. Nat. Prod. 52: 797-809, 1989.

Pairet, M., Churchill, L., Engelhardt, G.: Differential inhibition of cycloxoygenases 1 and 2 by NSAIDS. In: New targets of inflammation: Inhibitors of COX-2 or adhesion molecules. Eds.: N. Bazan, J. Botting, J. Vane, Kluwer Academic, Dordrecht, pp. 23-38, 1996.

Vane, J. R., Botting, J. R.: The history of anti-inflammatory drugs and their mechanism of action. In: New targets of inflammation: Inhibitors of COX-2 or adhesion molecules. Eds.: N. Bazan, J. Botting, J. Vane, Kluwer Academic, Dordrecht, pp. 1-12, 1996.

Wagner, H., Stuppner, H., Schafer, W., Zenk, M.: Immunologically active polysaccharides of Echinacea purpurea cell cultures. Phytochemistry 27:119-126, 1988.

L. J. Clifford (1)

M. G. Nair (2)

J. Rana (3)

D. L. Dewitt (4)

(1.) Department of Food Science and Human Nutrition and National Food Safety and Toxicology Center, Michigan State University, East Lansing, Michigan, USA

(2.) Department of Horticulture and National Food Safety and Toxicology Center, Michigan State University, East Lansing, Michigan, USA

(3.) Alticor Corporation, Ada, Michigan, USA

(4.) "Department of Biochemistry, Michigan State University, East Lansing, Michigan, USA

Address

M. G. Nair, Bioactive Natural Products and Phytoceuticals, 173 National Food Safety and Toxicology Center, Michigan State University, East Lansing, Michigan 48824, USA

Tel.: ++1-517-353-2915

Fax: ++1-517-432-2310

e-mail: nairm@msu.edu
COPYRIGHT 2002 Urban & Fischer Verlag
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2002 Gale, Cengage Learning. All rights reserved.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Author:Clifford, L.J.; Nair, M.G.; Rana, J.; Dewitt, D.L.
Publication:Phytomedicine: International Journal of Phytotherapy & Phytopharmacology
Geographic Code:1U3MI
Date:Apr 1, 2002
Words:2878
Previous Article:The anti-Inflammatory and analgesic effects of a crude extract of Petiveria alliacea L. (phytolaccaceae).
Next Article:Ginseng berry reduces blood glucose and body weight in db/db mice.


Related Articles
The vascular flora at Gerritsen Basin, New York.
Gardening: OFFER OF THE WEEK www .mirrorgarden.co.uk.
Echinacea.
Dr Miriam: Is this anti-flu herb a sham? LETTER OF THE DAY.
Your LIFE: OFFER OF THE WEEK; GARDENING.
OFFER OF THE WEEK.
OFFER OF THE WEEK.
Pharmacokinetics and immunomodulatory effects of phytotherapeutic lozenges (bonbons) with Echinacea purpurea extract.

Terms of use | Copyright © 2014 Farlex, Inc. | Feedback | For webmasters